参考文献/References:
[1] Roep BO,Kleijwegt FS,van Halteren AG,et al.Islet inflammation and CXCL10 in recent-onset type 1 diabetes[J].Clin Exp Immunol,2010,159（3）：338-343.
[2] Diana J,Simoni Y,Furio L,et al.Crosstalk between neutrophils,B-1a cells and plasmacytoid dendritic cells initiates autoim-mune diabetes[J].Nat Med,2013,19（1）：65-73.
[3] Ghazarian L,Diana J,Beaudoin L,et al.Protection against type 1 diabetes upon coxsackievirus B4 infection and iNKT-cell stimulation：role of suppressive macrophages[J].Diabetes,2013,
62（11）：3785-3796.
[4] Gur C,Porgador A,Elboim M,et al.The activating receptor NKp46 is essential for the development of type 1 diabetes[J].Nat Immunol,2010,11（2）：121-128.
[5] Feuerer M,Shen Y,Littman DR,et al.How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets[J].Immunity,2009,31（4）：654-664.
[6] Qin H,Lee IF,Panagiotopoulos C,et al.Natural killer cells from children with type 1 diabetes have defects in NKG2D-depen-dent function and signaling[J].Diabetes,2011,60（3）：857-866.
[7] Juno JA,Keynan Y,Fowke KR.Invariant NKT cells：regulation and function during viral infection[J].PLoS Pathog,2012,8（8）：e1002838.
[8] Blumenfeld HJ,Tohn R,Haeryfar SM,et al.Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice[J].Clin Exp Immunol,2011,166（1）：121-133.
[9] Joyee AG,Uzonna J,Yang X.Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection[J].J Immunol,2010,
184（4）：2095-2106.
[10] Diana J,Griseri T,Lagaye S,et al.NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner[J].Immunity,2009,30（2）：289-299.
[11] Roman-Gonzalez A,Moreno ME,Alfaro JM,et al.Frequency and function of circulating invariant NKT cells in autoimmune dia-betes mellitus and thyroid diseases in Colombian patients[J]. Hum Immunol,2009,70（4）：262-268.
[12] Ly D,Tohn R,Rubin B,et al.An alpha-galactosylceramide C20：2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes[J].Clin Exp Immunol,2010,160（2）：185-198.
[13] Grieco FA,Vendrame F,Spagnuolo I,et al.Innate immunity and the pathogenesis of type 1 diabetes[J]. Semin Immunopathol,2011,33（1）：57-66.
[14] Graham KL,Krishnamurthy B,Fynch S,et al.Intra-islet prolifer-ation of cytotoxic T lymphocytes contributes to insulitis progres-sion[J].Eur J Immunol,2012,42（7）：1717-1722.
[15] Tonkin DR,Haskins K.Regulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF-beta-dependent manner[J].Eur J Immunol,2009,39（5）：1313-1322.
[16] Lee MS,Kwon HJ,Kim HS.Macrophages from nonobese diabetic mouse have a selective defect in IFN-gamma but not IFN-alpha/beta receptor pathway[J].J Clin Immunol,2012,32（4）：753-761.
[17] Zhang J,Huang Z,Sun R,et al.IFN-gamma induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice[J].J Autoimmun,2011,38（1）：20-28.
[18] Parsa R,Andresen P,Gillett A,et al.Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice[J].Diabetes,2012,61（11）：2881-2892.
[19] Sia C,H?覿nninen A.Functional alterations of proinflammatory monocytes by T regulatory cells：implications for the prevention and reversal of type 1 diabetes[J].Rev Diabet Stud,2010,7（1）：6-14.
[20] Allen JS,Pang K,Skowera A,et al.Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture[J].Diabetes,2009,58（1）：138-145.
[21] Nieminen JK,Vakkila J,Salo HM,et al.Altered phenotype of peripheral blood dendritic cells in pediatric type 1 diabetes[J]. Diabetes Care,2012,35（11）：2303-2310.
[22] Delmastro MM,Piganelli JD.Oxidative stress and redox modulation potential in type 1 diabetes[J].Clin Dev Immunol,2011,
2011：593863.
[23] Giannoukakis N,Phillips B,Finegold D,et al.PhaseⅠ （safety） study of autologous tolerogenic dendritic cells in type 1 diabetic patients[J].Diabetes Care,2011,34（9）：2026-2032.
相似文献/References:
[1]袁扬,孙子林.PANDER与β细胞凋亡[J].国际内分泌代谢杂志,2007,(04):253.
[2]刘媛 刘超.1型糖尿病青少年儿童心理行为问题研究进展[J].国际内分泌代谢杂志,2015,(01):63.[doi:10.3760/cma.j.issn.1673-4157.2015.01.016]
Liu Yuan,Liu Chao..Psychological problems in adolescents and children with type 1 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):63.[doi:10.3760/cma.j.issn.1673-4157.2015.01.016]
[3]王思倩,吴锦丹.肠促胰素对1型糖尿病患者血糖及胰岛功能的影响[J].国际内分泌代谢杂志,2015,(03):196.[doi:10.3760/cma.j.issn.1673-4157.2015.03.015]
Wang Siqian,Wu Jindan..Effects of incretin on blood glucose and islet function in type 1 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(03):196.[doi:10.3760/cma.j.issn.1673-4157.2015.03.015]
[4]李亚兰,项洁,卜瑞芳.1型糖尿病的DiaPep277免疫治疗[J].国际内分泌代谢杂志,2014,(03):169.[doi:10.3760/cma.j.issn.1673-4157.2014.03.007]
Li Yalan,Xiang Jie,Bu Ruifang..Immunotherapy with DiaPep277 peptide in type 1 diabetes[J].International Journal of Endocrinology and Metabolism,2014,(03):169.[doi:10.3760/cma.j.issn.1673-4157.2014.03.007]
[5]蔡芸莹 苏恒.1型糖尿病的非胰岛素治疗[J].国际内分泌代谢杂志,2015,(06):388.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.007]
Cai Yunying,Su Heng.Noninsulin management in type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(03):388.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.007]
[6]王静 张梅.胰高血糖素在1型糖尿病治疗中的研究进展[J].国际内分泌代谢杂志,2018,38(01):19.[doi:10.3760/cma.j.issn.1673-4157.2018.01.005]
Wang Jing,Zhang Mei.Research progress of glucagon for the treatment of type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(03):19.[doi:10.3760/cma.j.issn.1673-4157.2018.01.005]
[7]朱婧 蒋晓红 项守奎 许晨 华飞.1型糖尿病患者尿酸水平与血脂异常的
相关性研究[J].国际内分泌代谢杂志,2020,40(01):16.[doi:10.3760/cma.j.issn.1673-4157.2020.01.004]
Zhu Jing,Jiang Xiaohong,Xiang Shoukui,et al.Correlation between uric acid level and dyslipidemia in patients with type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2020,40(03):16.[doi:10.3760/cma.j.issn.1673-4157.2020.01.004]
[8]周小海,安晔,王小玲,等.1型糖尿病合并非酒精性脂肪性肝病与慢性肾脏病的关系[J].国际内分泌代谢杂志,2021,41(04):339.[doi:10.3760/cma.j.cn121383-20200713-07032]
Zhou Xiaohai,An Ye,Wang Xiaoling,et al.Relationship between nonalcoholic fatty liver disease and chronic kidney disease in patients with type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2021,41(03):339.[doi:10.3760/cma.j.cn121383-20200713-07032]
[9]陈双,杨涛,顾愹.1型糖尿病的诊断与免疫治疗[J].国际内分泌代谢杂志,2021,41(06):578.[doi:10.3760/cma.j.cn121383-20210915-09046]
Chen Shuang,Yang Tao,Gu Yong..Diagnosis and immunotherapy of type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2021,41(03):578.[doi:10.3760/cma.j.cn121383-20210915-09046]
[10]齐晓洁,苏恒.1型糖尿病的二级预防临床研究进展[J].国际内分泌代谢杂志,2022,42(03):187.[doi:10.3760/cma.j.cn121383-20210129-01088]
Qi Xiaojie,Su Heng..Progress in secondary prevention of type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2022,42(03):187.[doi:10.3760/cma.j.cn121383-20210129-01088]